Consensus Benitec Biopharma Inc.

Equities

BNTC

US08205P2092

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-13 EDT			5-day change	1st Jan Change
8.12 ^USD	-12.22%		-2.40%	+151.39%

05-13	Benitec Biopharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
04-22	Benitec Biopharma Inc. announced that it has received $40.000019 million in funding from a group of investors	CI

Evolution of the average Target Price on Benitec Biopharma Inc.

Price target over the last 5 years

History of analyst recommendation changes

fd63a3799c6fa300a26be.lIkbHJF70QNMKP-5Qra7wq9rw4q7Y6JRg-ES6Ow7gQE.p75NQ8ZLpXIVXIzWIc7prOMNodXDAtE8yq5Vgpp1tDOg3UR63CuAZDxjkA~8e755f07fa2fb8cc52ba2bf0ba5e6d1a

Analyst Recommendations on Benitec Biopharma Inc.

JMP Securities Adjusts Benitec Biopharma's Price Target to $8 From $6, Keeps Market Outperform Rating	01-24	MT
JMP Securities Starts Benitec Biopharma at Market Outperform With $4 Price Target	22-10-18	MT
HC Wainwright Adjusts Price Target on Benitec Biopharma to $4 From $10, Reiterates Buy Rating	22-09-23	MT
HC Wainwright Initiates Benitec Biopharma at Buy With $10 Price Target	22-02-17	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

12.29 AUD

Average target price

24.91 AUD

Spread / Average Target

+102.63%

High Price Target

24.91 AUD

Spread / Highest target

+102.63%

Low Price Target

24.91 AUD

Spread / Lowest Target

+102.63%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Benitec Biopharma Inc.

JMP Securities
HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar